Leuprolide
Showing 1 - 25 of 405
Endometriosis Ovary Trial in Semarang (Dienogest, Depo Medroxyprogesterone acetate, Leuprolide (as Leuprolide Acetate))
Recruiting
- Endometriosis Ovary
- Dienogest
- +3 more
-
Semarang, Central Java, IndonesiaKariadi Hospital
Nov 22, 2023
Prostate Cancer Trial (Neoadjuvant treatment)
Not yet recruiting
- Prostate Cancer
- Neoadjuvant treatment
- (no location specified)
Oct 19, 2022
Puberty; Precocious, Central Trial (Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide)
Not yet recruiting
- Puberty; Precocious, Central
- Leuprolide Mesylate, Subcutaneous injection of 42 mg Leuprolide
- (no location specified)
Aug 5, 2022
Prostate Cancer, Prostatic Tumors Trial in Boston, Foxboro (Relugolix, Leuprolide)
Not yet recruiting
- Prostate Cancer
- Prostatic Neoplasms
- Relugolix
- Leuprolide
-
Boston, Massachusetts
- +2 more
Mar 1, 2023
Alzheimer, Mild Cognitive Impairment Trial in Boca Raton, New York, Madison (Placebo, Eligard 22.5Mg Suspension for Injection)
Recruiting
- Alzheimer Disease
- Mild Cognitive Impairment
- Placebo
- Eligard 22.5Mg Suspension for Injection
-
Boca Raton, Florida
- +2 more
Jan 24, 2023
Prostate Cancer Trial in Cleveland (Leuprolide acetate, Apalutamide, Radical prostatectomy)
Completed
- Prostate Cancer
- Leuprolide acetate
- +2 more
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
May 25, 2022
Endometriosis Trial in Quebec City (Leuprolide Oral Tablet 4-mg QD, Leuprolide Oral Tablet 4-mg BID, Leuprolide Depot)
Completed
- Endometriosis
- Leuprolide Oral Tablet 4-mg QD
- +3 more
-
Quebec City, Quebec, CanadainVentiv Health Clinique, Inc.
Jan 20, 2022
Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)
Active, not recruiting
- Leukemia
- +3 more
- Palifermin
- +6 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 23, 2023
Infertility, Endometriosis Trial in Lone Tree (Elagolix 200 MG, Leuprolide Acetate 3.75 MG/ML, Lab work)
Recruiting
- Infertility
- Endometriosis
- Elagolix 200 MG
- +2 more
-
Lone Tree, ColoradoColorado Center for Reproductive Medicine
Jul 20, 2022
Endometriosis Trial in United States (Leuprolide Oral Tablet - 120 mg - QD- Treatment A, Leuprolide Oral Tablet - 80 mg - QD -
Recruiting
- Endometriosis
- Leuprolide Oral Tablet - 120 mg - QD- Treatment A
- +4 more
-
Sarasota, Florida
- +3 more
Mar 21, 2022
Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,
Completed
- Prostate Adenocarcinoma
- +2 more
- Enzalutamide
- +3 more
-
Baltimore, Maryland
- +3 more
Mar 30, 2022
Angiogenesis, Endometriosis Trial in Patra, Yonago (Leuprolide Acetate)
Completed
- Angiogenesis
- Endometriosis
- Leuprolide Acetate
-
Patra, Peloponnese, Greece
- +1 more
Oct 27, 2023
Biochemically Recurrent Prostate Carcinoma, Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8 Trial in Atlanta
Recruiting
- Biochemically Recurrent Prostate Carcinoma
- +10 more
- Radiation therapy
- +2 more
-
Atlanta, Georgia
- +3 more
Jun 7, 2022
Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial
Not yet recruiting
- Locally Advanced Salivary Gland Carcinoma
- +3 more
- Biopsy
- +3 more
- (no location specified)
Jan 10, 2023
Central Precocious Puberty Trial (Leuprorelin Acetate Depot 3M)
Not yet recruiting
- Central Precocious Puberty
- Leuprorelin Acetate Depot 3M
-
Beijing, Beijing, China
- +4 more
Sep 21, 2022
Prostatic Tumors, Pelvic Nodal Trial in San Francisco (Enzalutamide, Leuprolide, Intensity-Modulated Radiation Therapy)
Terminated
- Prostatic Neoplasms
- Pelvic Nodal
- Enzalutamide
- +2 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Sep 14, 2021
Advanced Salivary Gland Carcinoma Trial in Shanghai (SHR-A1811, SHR 3680 + leuprolide, SHR-A1921)
Not yet recruiting
- Advanced Salivary Gland Carcinoma
- SHR-A1811
- +2 more
-
Shanghai, ChinaDongmei Ji
Jun 21, 2023
High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)
Not yet recruiting
- High-Risk Prostate Cancer
- Capivasertib
- abiraterone acetate
-
Portland, OregonVA Portland Health Care System, Portland, OR
Jan 17, 2023
Central Precocious Puberty Trial in Gyeonggi-do (Leuprolide Acetate 11.25 MG/ML)
Recruiting
- Central Precocious Puberty
- Leuprolide Acetate 11.25 MG/ML
-
Gyeonggi-do, Korea, Republic ofAjou University medical center
Aug 29, 2023
Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor
Not yet recruiting
- Androgen Deprivation Therapy
- +4 more
- Gonadotropin-Releasing Hormone Agonist
- +2 more
- (no location specified)
Jan 18, 2023
Central Precocious Puberty (CPP) Trial in Puerto Rico, United States (Leuprolide Acetate (LA))
Active, not recruiting
- Central Precocious Puberty (CPP)
- Leuprolide Acetate (LA)
-
Long Beach, California
- +20 more
Sep 9, 2022
Prostate Cancer Trial (Hypofractionated IMRT Radiation treatment)
Active, not recruiting
- Prostate Cancer
- Hypofractionated IMRT Radiation treatment
- (no location specified)
Sep 27, 2022